Japan Approves AstraZeneca’s Two Treatments For Asthma, Rare Form Of Cancer
Japan’s health agency has approved AstraZeneca Plc’s (NASDAQ:AZN) Koselugo (selumetinib) for pediatric patients with plexiform neurofibromas (PNs) in neurofibromatosis type 1…